한은택

Article

Discovery of novel TACE inhibitors using graph convolutional network, molecular docking, molecular dynamics simulation, and Biological evaluation

Conference

Combating malaria: targeting the ubiquitin-proteasome system to overcome drug resistance

Article

Identification of Marine Compounds Inhibiting NF-κBInducing Kinase Through Molecular Docking and Molecular Dynamics Simulations

Article

Estimation of PfRh5-based vaccine efficacy in asymptomatic Plasmodium falciparum patients from high-endemic areas of Tanzania using genetic and antigenicity variation screening

Article

Identification of Malaria-Selective Proteasome β5 Inhibitors Through Pharmacophore Modeling, Molecular Docking, and Molecular Dynamics Simulation

Conference

Repurposing HA-2025 as a Novel Nonsteroidal Inhibitor with Potent in vitro and in vivo Antimalarial Activity Against Drug-Resistant Plasmodium falciparum

Conference

Combating malaria: targeting the ubiquitin-proteasome system to overcome drug resistance

Conference

Geographical variation in immune responses to Plasmodium falciparum reticulocyte-binding protein homolog 5 (PfRh5)

Conference

Prevalence and molecular evidence of artemisinin-resistance Plasmodium falciparum in asymptomatic malaria in high and low malaria transmission hotspots in Tanzania

Conference

HA-2024, a dual-targeting proteasome inhibitor with potent anti-Plasmodial activity and favorable safety profile for orally malarial treatment

상세 보기

한은택

연구분야

자료유형

발행연도

키워드

언어

Discovery of novel TACE inhibitors using graph convolutional network, molecular docking, molecular dynamics simulation, and Biological evaluation

Combating malaria: targeting the ubiquitin-proteasome system to overcome drug resistance

Identification of Marine Compounds Inhibiting NF-κBInducing Kinase Through Molecular Docking and Molecular Dynamics Simulations

Estimation of PfRh5-based vaccine efficacy in asymptomatic Plasmodium falciparum patients from high-endemic areas of Tanzania using genetic and antigenicity variation screening

Identification of Malaria-Selective Proteasome β5 Inhibitors Through Pharmacophore Modeling, Molecular Docking, and Molecular Dynamics Simulation

Repurposing HA-2025 as a Novel Nonsteroidal Inhibitor with Potent in vitro and in vivo Antimalarial Activity Against Drug-Resistant Plasmodium falciparum

Combating malaria: targeting the ubiquitin-proteasome system to overcome drug resistance

Geographical variation in immune responses to Plasmodium falciparum reticulocyte-binding protein homolog 5 (PfRh5)

Prevalence and molecular evidence of artemisinin-resistance Plasmodium falciparum in asymptomatic malaria in high and low malaria transmission hotspots in Tanzania

HA-2024, a dual-targeting proteasome inhibitor with potent anti-Plasmodial activity and favorable safety profile for orally malarial treatment